GWP
GSK icon

Gateway Wealth Partners’s GSK GSK Stock Holding History

Gateway Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Buy
10,510
+6,415
+157% +$348K 0.02% 522
2025
Q4 		$201K Buy
+4,095
New +$191K 0.02% 450

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gateway Wealth Partners's GSK Position: Q1 2026 in Review

Gateway Wealth Partners increased its GSK (GSK) stake by 157% in Q1 2026, buying an estimated $348K and bringing the position to 10,510 shares worth $580K. The position accounts for 0.02% of the portfolio, ranked #522.

Gateway Wealth Partners first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Gateway Wealth Partners held 10,510 shares of GSK worth $580K as of Q1 2026.
  • Gateway Wealth Partners bought 6,415 GSK shares in Q1 2026, an estimated $348K.
  • GSK made up 0.02% of Gateway Wealth Partners's portfolio in Q1 2026, its #522 holding.
  • Gateway Wealth Partners first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.